Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. - Adams, R; Meade, A; Seymour, M; Wilson, R; Madi, A; Fisher, D; Kenny, S; Kay, E; Hodgkinson, E; Pope, M; Rogers, P; Wasan, H; et al. (Lancet. Oncology, 2011)